STOCK TITAN

Butterfly Network, Inc. - BFLY STOCK NEWS

Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.

Butterfly Network, Inc. (BFLY) is revolutionizing the healthcare landscape with its innovative digital health solutions, primarily focused on handheld, whole-body ultrasound technology. The company, which operates at the nexus of advanced engineering and scientific disciplines, has assembled a team of world-class talents in computer science, physics, and electrical engineering. Underpinned by a robust financial foundation from a select group of highly successful serial entrepreneurs, Butterfly Network is uniquely positioned to dedicate its full attention to product and intellectual property development.

Butterfly Network's flagship product, the Butterfly iQ+, represents a significant leap in medical imaging technology. This compact, user-friendly device leverages the company's proprietary Ultrasound-on-Chip technology to enable healthcare professionals to perform comprehensive whole-body imaging using a single handheld probe. The device's affordability and portability make it a game-changer in clinical settings, ensuring that high-quality ultrasound imaging is accessible and practical for a wide range of medical applications.

The integration of cloud-connected software with hardware technology further enhances the utility of the Butterfly iQ+, allowing for seamless data acquisition and analysis via a mobile application. This connectivity facilitates the practical application of ultrasound information within clinical workflows, thereby improving diagnostic capabilities and patient outcomes.

Recent achievements and ongoing projects include advancements in ultrasound technology and the expansion of the product's applications in various medical fields. The company's commitment to innovation is reflected in its continuous efforts to enhance the performance and capabilities of its devices.

With a strong focus on R&D and a strategic approach to technological development, Butterfly Network is poised to make significant contributions to digital health and medical imaging. The company's progress and updates can be closely followed through the latest news and press releases, which provide valuable insights into its performance, events, and developments.

Rhea-AI Summary
Butterfly Network and Forest Neurotech announce a five-year co-development agreement to develop the first implanted, whole-brain neural interface. The deal includes $20MM in milestones paid to Butterfly, with additional revenue anticipated upon commercialization for every unit sold.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.78%
Tags
none
-
Rhea-AI Summary
Butterfly Network to report Q3 2023 financial results and provide business update
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.84%
Tags
conferences earnings
-
Rhea-AI Summary
Butterfly Network introduces new ultrasound education offerings to boost POCUS competence and confidence.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.36%
Tags
AI
Rhea-AI Summary
Butterfly Network and Razom have expanded their global health partnership, bringing an additional 200 Butterfly iQ+ devices to Ukraine's war frontlines. Razom has already deployed over 400 devices in Ukraine. This partnership aims to enhance healthcare accessibility and quality in challenging circumstances.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.81%
Tags
partnership
-
Rhea-AI Summary
Indiana University School of Medicine adopts Butterfly iQ+ ultrasound technology for medical education
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.75%
Tags
none
-
Rhea-AI Summary
BFLY - Butterfly Network, Inc. Announces Reorganization Plan and Financial Results, Reports $18.5M Revenue for Q2 2023, Highlights Growth Initiatives and Upcoming Developments
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.26%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.26%
Tags
AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.02%
Tags
conferences earnings
-
Rhea-AI Summary
Butterfly Network, a digital health company, reported total revenue of $15.5 million for Q1 2023, in-line with guidance. They also reduced cash operating expense by 30%. The company received FDA clearance for their AI-enabled Auto B-Line Counter and signed contracts with a large U.S. academic medical center. However, product revenue decreased by 19.7% to $8.8 million. Butterfly Network's CEO expressed excitement about the disruption caused by the democratization of medical imaging.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.28%
Tags
Rhea-AI Summary

Butterfly Network, Inc. (NYSE: BFLY) announced it will report its first quarter 2023 financial results and provide a business update on May 11, 2023, prior to the market opening. The event will be followed by a conference call at 8:30 am ET, featuring key executives including CEO Joseph DeVivo and CFO Heather Getz. The call will be accessible via webcast on the company’s Investor Relations website and can also be joined by phone.

Butterfly, known for its revolutionary handheld ultrasound technology, aims to democratize medical imaging. The company’s focus on making ultrasound accessible globally aligns with its mission to enhance health equity. The innovative Butterfly iQ+ ultrasound device is now available to qualified healthcare practitioners across various regions worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.88%
Tags
conferences earnings

FAQ

What is the current stock price of Butterfly Network (BFLY)?

The current stock price of Butterfly Network (BFLY) is $3.24 as of November 22, 2024.

What is the market cap of Butterfly Network (BFLY)?

The market cap of Butterfly Network (BFLY) is approximately 673.3M.

What is Butterfly Network, Inc.?

Butterfly Network, Inc. is a digital health company focused on revolutionizing healthcare with its handheld, whole-body ultrasound technology.

What product does Butterfly Network offer?

The company's flagship product is the Butterfly iQ+, a handheld ultrasound device that utilizes proprietary Ultrasound-on-Chip technology for whole-body imaging.

How does the Butterfly iQ+ work?

The Butterfly iQ+ combines a handheld probe with cloud-connected software, allowing healthcare professionals to perform comprehensive whole-body imaging using a mobile application.

What makes Butterfly Network's technology unique?

Butterfly Network's technology is unique due to its Ultrasound-on-Chip technology, which enables high-quality imaging in a compact, affordable device that's easy to use.

Who funds Butterfly Network?

Butterfly Network is privately funded by a small group of extraordinarily successful serial entrepreneurs.

What are the recent achievements of Butterfly Network?

Recent achievements include advancements in ultrasound technology and the expansion of applications for their handheld devices across various medical fields.

How does Butterfly Network contribute to healthcare?

Butterfly Network contributes to healthcare by making high-quality ultrasound imaging accessible and practical, thus improving diagnostic capabilities and patient outcomes.

Is Butterfly Network publicly traded?

Yes, Butterfly Network, Inc. is publicly traded under the symbol BFLY.

Can the Butterfly iQ+ be used in multiple medical settings?

Yes, the Butterfly iQ+ is designed for use in a wide range of medical settings, providing versatile imaging capabilities.

Where can I find the latest news on Butterfly Network?

The latest news and updates on Butterfly Network can be found through their official press releases and stock market updates.

Butterfly Network, Inc.

NYSE:BFLY

BFLY Rankings

BFLY Stock Data

673.28M
155.32M
16.79%
27.54%
6.21%
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States of America
BURLINGTON